M&A Deal Summary

Allergan Acquires Anterios

On January 7, 2016, Allergan acquired life science company Anterios for 90M USD

Acquisition Highlights
  • This is Allergan’s 15th transaction in the Life Science sector.
  • This is Allergan’s 19th largest (disclosed) transaction.
  • This is Allergan’s 15th transaction in the United States.
  • This is Allergan’s 2nd transaction in New York.

M&A Deal Summary
Date 2016-01-07
Target Anterios
Sector Life Science
Buyer(s) Allergan
Deal Type Add-on Acquisition
Deal Value 90M USD

Target

Anterios

New York, New York, United States
Anterios, Inc. is a clinical stage biopharmaceutical company developing a next generation delivery system and botulinum toxin-based prescription products.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Allergan

Parsippany, New Jersey, United States
Category Company
Founded 1956
Sector Life Science
Employees31,200
Revenue 15.8B USD (2018)
DESCRIPTION

Allergan is an integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. The Company was originally established in 1956 and is based in Parsippany, New Jersey.

DEAL STATS #
Overall 24 of 38
Sector (Life Science) 15 of 23
Type (Add-on Acquisition) 19 of 31
State (New York) 2 of 2
Country (United States) 15 of 27
Year (2016) 1 of 9
Size (of disclosed) 19 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-04 Northwood Medical Innovation

Marlow, United Kingdom

Northwood Medical Innovation Ltd. is a developer of innovative implant technology earFold. It is an innovative medical device for the correction of prominent ears, with or without asymmetry, in patients aged 7 years and older.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-04-21 Topokine Therapeutics

Boston, Massachusetts, United States

Topokine Therapeutics, Inc. is a clinical-stage biotechnology company developing topical prescription medications to contour the face and body non-invasively.

Buy $85M
Mergr

Product

Company

Legal